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The type II AAA ATPase p97 interacts with a large
number of cofactors that regulate its function by re-
cruiting it to different cellular pathways. Most of the
cofactors interact with the N-terminal (N) domain of
p97, either via ubiquitin-like domains or short linear
binding motifs. While some linear binding motifs
formahelices, anothergroup features short stretches
of unstructured hydrophobic sequences as found in
the so-called SHP (BS1, binding segment 1) motif.
Here we present the crystal structure of a SHP-bind-
ing motif in complex with p97, which reveals a so far
uncharacterized binding site on the p97 N domain
that is different from the conserved binding surface
of all other knownp97cofactors. This finding explains
how cofactors like UFD1/NPL4 and p47 can utilize a
bipartite binding mechanism to interact simulta-
neously with the same p97 monomer via their ubiqui-
tin-like domain and SHP motif.
INTRODUCTION
p97 is a type II AAA ATPase (ATPase associated with a variety
of cellular activities) (Ogura and Wilkinson, 2001; Wendler
et al., 2012) with many roles in diverse biological functions,
including ER-associated protein degradation (ERAD) and the
ubiquitin proteasome system, but also fulfilling non-proteolytic
functions (reviewed in Meyer et al., 2012; Meyer and Weihl,
2014; Stolz et al., 2011). This functional diversity is mediated
with the help of a large variety of cofactors (reviewed in Yeung
et al., 2008). p97 forms a hexamer with two stacked rings
formed by the two ATPase domains (D1 and D2) with an N-ter-
minal (N) domain attached to the D1 ring (Davies et al., 2008;
Huyton et al., 2003). Cofactors either bind to the unstructured
C terminus or the N domain. Due to its involvement in several
important cellular processes, defects in interactions between
p97 and its binding partners contribute to various diseases,
while p97 itself has been linked to cancer and a wide variety
of neurodegenerative disorders (reviewed in Meyer and Weihl,
2014). Mutations in p97 are causative of two fatal protein ag-
gregation diseases (proteinopathies): inclusion body myop-
athy with Paget’s disease of the bone and frontotemporal140 Structure 24, 140–147, January 5, 2016 ª2016 Elsevier Ltd All rigdementia (IBMPFD) and familial amyotrophic lateral sclerosis
(fALS) (Meyer and Weihl, 2014).
Currently known cofactors interact with the N domain via
either a ubiquitin regulatory X (UBX) domain and other domains
with a ubiquitin-like fold (UBX-like, UBXL) or through one of
several linear binding motifs (Morreale et al., 2009; Yeung
et al., 2008). The latter include the VCP-interacting motif (VIM),
the VCP-binding motif (VBM), and the SHP motif (also known
as binding site 1 [BS1]). The VIM and VBM motifs are short
Arg/Lys-rich peptide stretches that bind as a helices to p97
(Ha¨nzelmann and Schindelin, 2011; Liu et al., 2013a), whereas
the SHP-bindingmotif is a short sequence stretch enriched in hy-
drophobic amino acids. Although there is no sequence similarity
between the VIM-binding motif (Ha¨nzelmann and Schindelin,
2011) and the UBX domain (e.g., Dreveny et al., 2004; Ha¨nzel-
mann et al., 2011) or UBXL domains (Isaacson et al., 2007; Kim
et al., 2014), the binding sites partly overlap and all cofactors
bind to the same general area centered on the hydrophobic inter-
domain cleft between the two subdomains of p97 N, thus ex-
plaining why these cofactors compete with each other (Ballar
et al., 2006; Bruderer et al., 2004; Ha¨nzelmann and Schindelin,
2011; Meyer et al., 2000; Nagahama et al., 2003).
There are two major cofactors of p97, the UFD1/NPL4 com-
plex and p47, which form independent complexes with p97.
UFD1 and NPL4 form a heterodimer (Meyer et al., 2000; Pye
et al., 2007): UFD1 comprises (Figure 1A) an N-terminal domain
(UT3), which is structurally similar to the N domain of p97 and
contains binding sites for both poly- and mono-ubiquitin (Park
et al., 2005; Rumpf and Jentsch, 2006), and a C-terminal domain
(UT6) involved in NPL4 binding also harboring a SHP-binding
motif (SHP1) for p97 interaction (Bruderer et al., 2004). NPL4 is
composed of an N-terminal UBXL domain that interacts with
p97 (Bruderer et al., 2004; Isaacson et al., 2007), a C-terminal
zinc finger domain (NZF) domain that binds ubiquitin (Wang
et al., 2003), and a centrally located catalytically inactive MPN
domain of unknown function (Figure 1A). The interaction be-
tween the heterodimeric UFD1/NPL4 and p97 is bipartite as it
is mediated through the SHP1 motif in UFD1 and the UBXL
domain of NPL4 (Bruderer et al., 2004). It has been proposed
that these sites interact with two different N domains (Isaacson
et al., 2007). p47 contains three domains connected by long flex-
ible regions (Figure 1A): an N-terminal UBA (ubiquitin-associ-
ated) domain involved in ubiquitin interaction, a central SEP
domain, which is involved in trimerization, and a C-terminal
UBX domain that interacts with p97 (Beuron et al., 2006; Dreveny
et al., 2004). The flexible linker connecting the SEP and UBXhts reserved
Figure 1. The SHP-Binding Motif
(A) Domain architectures of heterodimeric UFD1/
NPL4 and p47.
(B) Sequence alignment of SHP-binding motifs
currently identified in human proteins. Strictly
conserved residues are highlighted with a black
background and similar residues with a gray
background.
(C) Top, surface representation of the p97N hy-
drophobic interdomain cleft, with residues impor-
tant for UBX, VIM, and VBM cofactor interactions
labeled. Bottom, streptavidin pull-down assays
involving biotinylated peptides (UFD1-SHP1 and
gp78-VIM) or GST pull-down assay (UBE4B-VBM)
with p97ND1 wt and variants.domains harbors a SHP motif. Like UFD1/NPL4, p47 also uses a
bipartite mechanism to associate with p97 (Bruderer et al., 2004)
utilizing its SHP motif and UBX domain.
Currently there is only limited structural information available
as to how the SHP motif interacts with the N domain of p97.
The SHP-binding site on p97 has been controversial, and either
an alternative binding site (Bruderer et al., 2004) or a partially
overlapping binding site with the UBXL of NPL4 (Isaacson
et al., 2007) has been suggested. The crystal structure of the
p97ND1-p47-UBX/SHP complex revealed that the SHP motif
forms a crystal lattice contact with the N domain of a different
hexamer (Dreveny et al., 2004). The observed binding site, which
is different from the hydrophobic interdomain cleft of the N
domain, was in agreement with an alternative binding site yet it
was not characterized.
Here we present the crystal structure of p97 in complex with a
SHP-binding motif, namely a peptide derived from UFD1, which
revealed a so far uncharacterized interaction site on the N
domain that is different from the binding surface of other p97 co-
factors. The association of the SHP-binding motif on the lateral
surface of the N domain and of UBX/UBXL domains in the hydro-
phobic interdomain cleft on top of the N domain allows for a
bipartite binding of both binding domains/motifs to either the
same N domain or to two adjacent N domains. This bipartite
interaction mode not only increases the affinity but also restricts
the conformational flexibility of p97.
RESULTS
Does the SHP-Binding Motif Target the Hydrophobic
p97 N Interdomain Cleft?
The SHP-binding sequence which was first identified in Shp1,
the yeast ortholog of p47, and in Dfm1p (Sato and Hampton,
2006), the yeast derlin 1 protein, was mapped to a short hydro-
phobic sequence stretch containing two invariant Gly residues
and is typically characterized (Figure 1B) by the consensusStructure 24, 140–147, January 5, 2016sequence FxGxGx2h (x, any amino acid;
h, hydrophobic amino acid). The binding
sequence is highly variable and typically
found in an unstructured region of the
protein. In mammals, this motif is found
in the SEP domain containing UBX pro-
teins p37, p47, UBXD4, and UBXD5 andin the UBX protein ASPL (Kloppsteck et al., 2012). The SHPmotif
is located N-terminally of the UBX domain, to which it is con-
nected via a mainly unstructured linker. Additional SHP-binding
motif-containing proteins are UFD1 (Bruderer et al., 2004), DVC1
(Spartan) (Mosbech et al., 2012), which functions in DNA repair
coupled to DNA replication, and the DERLIN proteins (DER1
and DER2), which are involved in ERAD (Greenblatt et al.,
2011; Huang et al., 2013). In UFD1, a second SHP motif
(SHP2) was identified located at its extreme C terminus, which,
however, seems not to be involved in interactions with p97 (Bru-
derer et al., 2004).
Initial streptavidin pull-down assays using a biotinylated UFD1
peptide covering the SHP1 motif revealed a strong binding to
full-length p97 and the ND1 fragment (Figure 1C), whereas only
a very weak interaction with the isolated N domain could be de-
tected (data not shown), thus suggesting that further structural
elements like the linker between the N and D1 domain and/or
the D1 domain are required. To further characterize this interac-
tion, we analyzed ND1 variants (Figure 1C) of the N domain hy-
drophobic interdomain cleft, which harbors the binding region
for UBX and VIM proteins (Ha¨nzelmann et al., 2011; Ha¨nzelmann
and Schindelin, 2011). However, the streptavidin pull-down
assay did not show a significant effect with any of the tested var-
iants. These data suggest that the SHP motif utilizes a different
and so far uncharacterized binding site. In contrast, the VIM of
gp78 and the GST-tagged VBM of UBE4B, which is involved in
multi-ubiquitin chain assembly (Laser et al., 2006), revealed a
largely impaired interaction with most of the residues, confirming
the proposed binding site of the VBM on the N domain (Liu et al.,
2013a) as being similar to the VIM-binding region.
The Structural Basis for p97-SHP Binding
To elucidate the molecular basis of SHP recognition by p97, we
determined the crystal structure of full-length p97 in complex
with a UFD1-derived peptide encompassing the SHP1 motif.
The 3.1-A˚ structure was solved by molecular replacement andª2016 Elsevier Ltd All rights reserved 141
Table 1. Data Collection and Refinement Statistics
Data Collection
Wavelength (A˚) 0.97625
Resolution (A˚) 49.14–3.08 (3.13–3.08)
Space group P212121
Cell dimensions
a, b, c (A˚) 140.7, 180.7, 255.0
Unique reflections 120,596
<I/s(I)> 12.8 (1.1)
Completeness (%) 100 (99.9)
Redundancy 11.0 (10.9)
Rsym 0.116 (2.495)
Rpim 0.053 (1.155)
CC (1/2) 0.999 (0.527)
Refinement
Resolution limits (A˚) 49.14–3.08
Number of reflections 120,478
Rcryst/Rfree 0.198 (0.240)
Number of atoms
Protein (non-hydrogen) 34,227
Ligands 402
Solvent atoms 30
Root mean square deviations in
Bond lengths (A˚) 0.003
Bond angles () 0.730
Coordinate error (A˚) 0.40
Average B factors (A˚2)
Overall 146
N (chain D)a 184
D1 (chain D)a 136
D2 (chain D)a 140
UFD1 peptide (chain V)a 220
Ramachandran Statistics (%)
Favored 96.21
Allowed 3.10
Outliers 0.69
aB factors are for the p97-UFD1 peptide complex found in chains D and
V.Statistics for the highest-resolution shell are shown in parentheses.was refined to Rfree and R values of 24.0% and 19.8%, respec-
tively (Table 1). A region of unassigned electron density in two
of the six N domains was found in both the 2Fo  Fc and
Fo  Fc electron density maps (Figure 2A). Eleven residues
(amino acids [aa] 225–235) of the 21-amino acid peptide were
defined and could be modeled (Figure 2A). The peptide adopts
a mostly extended conformation and is attached on the outside
of the C-terminal a + b subdomain (Nc, aa 112–186) of the N
domain in a region that is directly adjacent to the ND1 linker (Fig-
ure 2B). The peptide associates with two b strands of the four-
stranded b sheet, and is further stabilized by an a helix. Although
the N domains in this structure are rather flexible, and many side
chains are disordered, which are further translated to the bound
peptide (average B factors for all atoms: N, 184 A˚2; D1, 136 A˚2;
D2, 140 A˚2; UFD1 peptide, 220 A˚2), it was possible to assign142 Structure 24, 140–147, January 5, 2016 ª2016 Elsevier Ltd All rigthe N-terminal part of the peptide including the twoPhe residues.
However, in the region of the invariant GxG motif, the electron
density is less well defined and the side chain orientation of the
following C-terminal part is not entirely clear. Participating resi-
dues from p97 include R113, H115, F131, and H183, and in
UFD1, residues F225, F228, and R234 are involved (Figure 2C).
The interaction is mainly hydrophobic in nature, and only a few
electrostatic contacts are observed. UFD1 F225 is involved in
hydrophobic interactions with L117 of p97, while p97 R113
and UFD1 R234 engage in hydrophobic contacts via their long
aliphatic side chains with UFD1 F228 and p97 F131, respec-
tively. The side chains of the p97 H115 and H183 are in
hydrogen-bonding distance to the main-chain atoms of A227,
S229, and S231 in UFD1.
Analysis of the p97-SHP Interface
Amutational analysis was carried out to determine the functional
significance of the molecular interactions observed in the com-
plex. Streptavidin pull-down assays revealed that R113, H115,
F131, and H183 of p97 are important, with the single F131A
andH183A variants already completely abolishing the interaction
(Figure 2D). E185 largely retained the ability to interact with p97,
andV181was found not to be involved. For theUFD1-SHP1motif
peptide, these studies revealed that F225, F228, and R234
contributed significantly to binding, whereas N233 and L235
only played a minor role (Figure 2E). These data clearly validated
the binding mode observed in the crystal structure.
To confirm that the data obtained with the peptide also apply
to the full-length protein an isothermal titration calorimetry (ITC)
analysis of the heterodimeric UFD1/NPL4 complex with the
p97ND1 fragment was carried out (Figures 3 and S1). The p97
Ala variants of R113, H115, F131, and H183 showed a largely
reduced interaction (7- to 16-fold decrease in the dissociation
constant KD) compared with the wild type (wt), whereas the
E185A substitution did not alter the affinity (Figures 3B and
S1). The same applied to the UFD1 variants as already single
Ala substitutions of F225, F228, and R234 showed an impaired
interaction, with a 5- to 8-fold decrease in KD (Figures 3C and
S1). As mentioned earlier, UFD1 contains, at its extreme C termi-
nus, 65 amino acids downstream of the verified SHP motif
(SHP1), a closely related second SHP (SHP2) sequence (Fig-
ure S2A) located in an unstructured region, which, theoretically,
could associate with an additional N domain and thereby provide
evenmore specificity. However, based on aGST pull-down anal-
ysis of a short fragment comprising the last 26 residues of UFD1,
no interaction with p97 was detected (Bruderer et al., 2004),
which may be explained by the exchange of the important
SHP1 R234 with a Ser (Figure S2A). Nevertheless, an ITC anal-
ysis using the heterodimeric UFD1/NPL4 complex in which the
last 21 amino acids of UFD1 were missing (DSHP2), revealed a
3-fold decrease in affinity (Figures S2B and S2C), suggesting a
weak contribution of SHP2 to the binding affinity. However, since
single SHP1 mutants displayed an even more severe effect (Fig-
ure 3C), it cannot be ruled out that structural changes are the
reason for the weaker affinity. Interestingly, a UFD1 mutant,
where both binding motifs were swapped, still showed an affinity
comparable with the wt protein (Figures S2B and S2C), indi-
cating that the SHP2 motif is functional if it is located in the
proper position. These data point toward an interplay betweenhts reserved
Figure 2. Structure of p97 in Complex with
the UFD1-SHP1-Binding Motif
(A) Top, SIGMAA-weighted 2Fo  Fc electron
density map of the UFD1 peptide shown in stick
representation (colored according to atom type
with C atoms in purple) contoured at 0.9 times
the root mean square deviation (RMSD), with a
cartoon representation of the N domain in cyan
and the D1 domain in gray. Bottom, Unbiased
SIGMAA-weighted Fo  Fc electron density map
contoured at 2.8 times the RMSD.
(B) Cartoon representation of p97 in complex with
the UFD1 peptide (Nn and Nc subdomains are
shown with b strands in cyan and a helices in blue,
D1 in gray, ND1 linker in black, UFD1 peptide in
purple, D2 not shown).
(C) Cartoon representation of the binding inter-
face. Residues involved in binding are shown in
stick representation, with the UFD1 peptide
colored in purple and p97N residues in cyan.
Dashed lines indicate putative H bonds.
(D) Streptavidin pull-down assays of biotinylated
UFD1-SHP1 wt peptide with p97ND1 (wt and
variants).
(E) Streptavidin pull-down assays of p97ND1 wt
with biotinylated UFD1-SHP1 peptides (wt and
variants).both SHP motifs, which may be even more pronounced when
additional cofactors are present. Whether both motifs can also
be used in vivo remains to be elucidated.
To further investigate the functional significance of the SHP
motif and to find out whether the observed binding mode also
applies to other SHP motif-containing proteins, we analyzed
the UBX protein p47, since it contains the SHP motif and UBX
domain on the same polypeptide separated only by a linker.
Interestingly, an earlier crystal structure of the ND1 fragment of
p97 in complex with the C-terminal region of p47, composed
of its UBX domain and SHPmotif (Dreveny et al., 2004), revealed
that the SHP motif forms a lattice contact with the Nc domain
from a different hexamer instead of associating with its own N
domain (Figure 3D). Nevertheless, the binding region involving
H115, F131, and H183 is identical to the identified UFD1-SHP-
binding site (Figure 3E), and the flexible linker connecting the
UBX domain and the SHP-binding motif would be of sufficient
length to also allow the association of the SHP motif with the
same N domain to which UBX is bound (Figure 3D). Since the
interaction site present in this structure was not further charac-
terized, we conducted ITC analyses of wt p47 and ND1 variants.
These studies yielded similar results as for UFD1/NPL4, with the
F131A and H183A variants displaying the largest reduction in
binding, thus indicating a conserved interaction mode (Figures
3F and S3A) with the exception of the H115A variant, which
showed only a slight decrease (2-fold) in affinity. This difference
could be due to the different binding modes involving either two
proteins in the case of the UFD1/NPL4 heterodimer, or just oneStructure 24, 140–147, January 5, 2016protein for p47, which, in the latter case,
may restrict the way in which the SHP
motif interacts with its binding surface.
The structure of the NPL4-UBXL
domain was solved by nuclear magneticresonance and, based on chemical shift experiments, a struc-
tural model for the p97NNPL4-UBXL complex was calculated
(Isaacson et al., 2007). Based on this model, R8 as well as F76
make significant contributions to p97N binding (Figure 3A). We
introduced Ala residues at both positions to elucidate the contri-
bution of NPL4 binding to p97. While the UFD1/NPL4-F76A
variant could not be purified in sufficient amounts, indicating
that the removal of the bulky hydrophobic side chain affects pro-
tein stability, the UFD1/NPL4-R8A variant significantly impaired
the interaction to a similar extent as observed for the UFD1 var-
iants in ITC experiments (Figures 3C and S1). In addition, anal-
ysis of the two N domain variants (Figures 3B and S1), D55A
and Y110A, residues that are involved in interactions with the
UBXL of NPL4 (Figure 3A), and hence should not interfere with
binding of the SHPmotif, almost completely abolished this inter-
action (40- to 50-fold decrease in KD). In contrast, based on the
structure of the p47-UBX domain bound to p97ND1 (Dreveny
et al., 2004), D55 is not involved in the interaction with this
UBX domain, and Y110 only makes a minor contribution.
Accordingly, ITC analysis revealedwt affinity for the D55A variant
and only a 2-fold decrease in the affinity for the Y110A variant
(Figure S3B), which further demonstrated that D55 and Y110
were not involved in SHP binding, and that the binding defect
with UFD1/NPL4 was the consequence of an abolished NPL4
interaction. Earlier studies proposed that the NPL4-UBXL is the
general p97-binding domain and that binding of UFD1 provides
higher affinity and positions the cofactor in the correct orienta-
tion with respect to p97 for interaction with ubiquitylatedª2016 Elsevier Ltd All rights reserved 143
Figure 3. Interaction of p97 with UFD1/
NPL4 and p47
(A) Cartoon representation of p97N (colored in
gray) in complex with the NPL4-UBXL domain
(PDB: 2PJH; Isaacson et al., 2007, colored in blue)
and the UFD1-SHP1-binding motif (colored in
purple) as amodel for bipartite binding to the same
N domain. Residues involved in binding are shown
in stick representation colored according to atom
type.
(B) ITC analysis of p97ND1 (wt and variants) with
UFD1/NPL4 wt. See also Figure S1.
(C) ITC analysis of p97ND1wt with UFD1/NPL4 (wt
and variants). See also Figures S1 and S2.
(D) Superposition of the p97NUFD1-SHP1 (N
colored in cyan, UFD1-SHP colored in purple) and
p97Np47-UBX/SHP complexes (PDB: 1S3S
(Dreveny et al., 2004), with the N domain in dark
gray, symmetry-related N domain in medium gray,
UBX in light gray, p47-SHP in orange, UBX-SHP
linker in green). Residues involved in binding are
shown in stick representation colored according
to atom type. The arrow relates the SHP peptides.
(E) Superposition of the UFD1 (p97N colored in
cyan, SHP colored in purple) and p47 (1S3S;
Dreveny et al., 2004, p97N colored in gray, SHP
colored in orange) SHP-binding motifs.
(F) ITC analysis of p97ND1 (wt and variants) with
p47 wt. See also Figure S3A.substrates (Bruderer et al., 2004). However, our data clearly
show that a bipartite binding mode involving both the UBXL
and SHP is essential for the interaction with p97, with the
UBXL domain apparently making a stronger contribution.
Already single variants either affecting UBXL/UBX or SHP bind-
ing largely impaired the interaction of p97 with its UFD1/NPL4
and p47 cofactors.
DISCUSSION
The data presented here characterize in detail a binding surface
on the N domain, which associates with the SHP motifs of UFD1
and p47. This site is different from the common binding site of
UBX and UBXL domains, as well as the a-helical VIM- and
VBM-binding motifs, which all interact with the hydrophobic in-
terdomain cleft formed between the two subdomains of the N
domain (Figure 4A). Unlike the UBX domain and the VIM-binding
motif, the SHPmotif does not recognize an isolated N domain (aa
1–187). This can be explained by the fact that the binding surface
on the N domain includes residues from the last b strand that144 Structure 24, 140–147, January 5, 2016 ª2016 Elsevier Ltd All rights reservedprecedes the ND1 linker, as well as
E185, the first residue of the linker.
Furthermore, a superposition of the N
domain in complex with the SHP peptide
and the isolated N domain revealed an
altered conformation of aa 183–187,
which would prevent SHP binding
(Figure S4).
The crystal structure of the p97p47-
UBX/SHP complex together with the
identification of the UFD1-SHP-bindingsite on the Nc subdomain, indicate that both binding domains/
motifs may associate with the same N domain and do not
bind to two adjacent N domains, at least for UBX proteins like
p47 that contain both domains/motifs on the same polypeptide
separated by a flexible linker (Figure 4B). In theory, this would
allow additional cofactors to assemble with a p97 hexamer via
unoccupied N domains (see later). This would be consistent
with the earlier finding that both isolated binding motifs/do-
mains can bind independently (Bruderer et al., 2004). However,
it cannot be ruled out that the long flexible linker adopts a
different conformation mediated by the embedded Pro residues
(Figure 3D) and points in the opposite direction so that the SHP
motif binds to an adjacent N domain. Both models would be
consistent with electron microscopy (EM) studies of the
p97p47 complex in different nucleotide states (Beuron et al.,
2006), suggesting that, during ATP hydrolysis, binding of
trimeric p47 via its UBX domains either involves only every sec-
ond N domain or all six N domains where the UBX domain and
its upstream linker are bound between two adjacent N domains
(Figure 4B).
Figure 4. Cofactor Binding to the p97 N
Domain
(A) Ribbon representations together with the mo-
lecular surface of p97N in complex with the VIM of
gp78 (PDB: 3TIW; Ha¨nzelmann and Schindelin,
2011, colored in green), FAF1-UBX (PDB: 3QQ8;
Ha¨nzelmann et al., 2011, colored in gold) and
NPL4-UBXL (PDB: 2PJH; Isaacson et al., 2007,
colored in blue). The UFD1-SHP1 peptide (colored
according to atom type with C-atoms in purple) is
shown in stick representation. See also Figure S4.
(B) Models for the interaction of p97, with either
p47 (left two panels) or UFD1/NPL4 (right two
panels) involving bipartite binding to either
different (left in each case) or identical (right in
each case) N domains.In the case of UFD1/NPL4, where the binding domains/motifs
reside on separate proteins, the mode of bipartite binding is still
undefined. Although it has been proposed that the NPL4-UBXL
domain and the UFD1-SHP-binding sites are on adjacent N do-
mains (Isaacson et al., 2007), and despite the existence of EM
structures depicting the p97UFD1/NPL4 complex (Bebeacua
et al., 2012; Pye et al., 2007), there is currently no direct evidence
for this model (Figure 4B). Earlier studies showed that chemical
shift perturbations induced in spectra of p97 N in the presence
of an UFD1-SHP1 peptide are reversed upon the addition of
the NPL4-UBXL domain, which suggests a degree of communi-
cation between the NPL4- and UFD1-binding sites on p97
(Isaacson et al., 2007). These data would be in agreement with
the crystal structure of p97 in complex with the UFD1-SHP1
motif and the structural model for the p97NNPL4-UBXL com-
plex (Isaacson et al., 2007). The last ordered residues of the pep-
tide are in close proximity to the UBXL, and the C terminus of the
UBXL points toward the peptide (Figure 4A), suggesting some
degree of steric hindrance between the full-length proteins,
thus favoring a model with binding sites on two adjacent N do-
mains (Figure 4B). In contrast, based on the work with peptides
of the UFD1 and p47 SHP motifs, and the isolated NPL4-UBXL
and p47-UBX domain, it could be shown in pull-down experi-
ments that both binding motifs/domains bind independently
(Bruderer et al., 2004), indicating binding to the same N domain.
Thus, none of the proposed models can be ruled out at this time
(Figure 4B).
Whether cofactors always stay associated via both binding
motifs is not known. It is conceivable that, for example, during
ATP hydrolysis or substrate-binding, conformational changes
are induced that lead to the dissociation of one site, thus weak-
ening the interaction and resulting in an increased conforma-
tional flexibility of the cofactor for subsequent catalysis. Such aStructure 24, 140–147, January 5, 2016model would be in accordance with the
conformational variability observed in
the EM structures of the p97UFD1/
NPL4 complex in different nucleotide
state where the heterodimer is bound
either via two or just a single binding site
(Bebeacua et al., 2012) and the EM
studies of the p97p47 complex as
described above (Beuron et al., 2006).Irrespective of the question whether the same or different N do-
mains are targeted, due to avidity effects, a bipartite binding
generally enhances the affinity of individually weaker interactions
and allows for greater binding specificity.
Structural studies of IBMPFD-associated p97 mutants re-
vealed dramatic nucleotide-dependent conformational changes
in the position of the N domain (Tang et al., 2010), and an altered
interaction with cofactors has been shown in vivo (Fernandez-
Saiz and Buchberger, 2010). In particular, increased amounts
of UFD1/NPL4 and p47 were found in cells. The movement of
the N domains from a position in a plane with the D1 domain to
a position above the D1 domain could bring the cofactors into
close spatial proximity, leading to a tighter binding on top of
p97 assisted by an enhanced bipartite binding mode.
One of the key questions regarding the biological function of
p97 is how this highly abundant ATPase participates in so
many dissimilar processes? This functional diversity is mainly
the result of its association with a large variety of cofactors,
which is regulated by multiple mechanisms (reviewed in Buch-
berger et al., 2015). The heterodimeric UFD1/NPL4 and trimeric
p47 cofactors form p97 complexes differ significantly in stoichi-
ometry and symmetry, providing the structural basis for the
mutually exclusive binding of p47 and UFD1/NPL4 to p97 (Bru-
derer et al., 2004; Meyer et al., 2000). Since only one heterodi-
meric UFD1/NPL4 cofactor binds to the p97 hexamer, further co-
factors could potentially bind to vacant N domains. Indeed, it
was shown that immunoprecipitates of the UBA-UBX proteins
FAF1, UBXD7, UBXD8, and SAKS1 contained not only p97,
but also UFD1/NPL4 (Alexandru et al., 2008), an observation
that is consistent with the existence of higher-order p97-cofactor
complexes. In addition to the UBA-UBX proteins discussed
earlier, the UFD1/NPL4 heterodimer was also found in quarter-
nary complexes with p97 and the deubiquitinating (DUB) enzymeª2016 Elsevier Ltd All rights reserved 145
Otu1/YOD1 (Ernst et al., 2009; Kim et al., 2014), the VBM
cofactor NUB1L (Liu et al., 2013b), and the VIM protein SelS/
VIMP (Ye et al., 2004). In addition, for p47, it was proposed
that the DUB VCIP135 forms, via its UBXL domain, an unstable
ternary complex, where p47 would be associated via only one
of its binding sites (Uchiyama et al., 2002).
In summary, our structural and functional characterization of
the bipartite binding mode of UFD1/NPL4 and p47 provides
crucial insights into p97 cofactor specificity/diversity, and the as-
sembly of higher-order p97-cofactor complexes, which is tightly
controlled by multiple regulatory mechanisms including mutually
exclusive binding, different oligomeric assemblies, and nucleo-
tide-dependent conformational changes.
EXPERIMENTAL PROCEDURES
Cloning, Site-Directed Mutagenesis, Protein Expression, and
Purification
The following constructs were used in this study: human full-length p97 (aa 1–
806), p97N (aa 1–187), p97ND1 (aa 1–480), human UFD1 and NPL4, human
p47 (Ha¨nzelmann et al., 2011; Ha¨nzelmann and Schindelin, 2011); human
GST-tagged UBE4B-VBM (aa 1–23, pETM30, EMBL Heidelberg, NcoI/XhoI).
p97D709-728 was generated by PCRmutagenesis. For site-directed mutagen-
esis, the QuikChange II Site-Directed Mutagenesis Kit from Agilent was used.
Unmodified as well as N-terminally biotinylated (Biotin-Ahx) human peptides
were purchased from Genscript: UFD1 (221GELGFRAFSGSGNRLDGKKKG241),
gp78 (622VTLRRRMLAAAAERRLQKQ640). Protein expression and purification
was performedas described usingmetal-affinity and size-exclusion chromatog-
raphy (Ha¨nzelmannet al., 2011;Ha¨nzelmannandSchindelin, 2011). Thepurifica-
tion protocol of p97D709-728 included an additional anion-exchange chroma-
tography step (Q-sepharose FF, GE Healthcare) using a 100 mM HEPES (pH
7), 50 mM NaCl, and 5 mM b-mercatoethanol buffer, and a linear NaCl gradient
(0.05–500 mM).
Crystallization
For crystallization of p97D709-728 in complex with the UFD1 peptide,
p97D709-728 was incubated with ATPgS and the peptide at a molar ratio of
1:15:5 (0.1 mM p97, 1.5 mMATPgS, and 0.5mM peptide) for 1 hr at 4C. Crys-
tals were grown at 20C by vapor diffusion in hanging drops containing equal
volumes of protein in 10 mM HEPES (pH 8), 100 mM NaCl, 5 mM MgCl2, and
1 mM TCEP, and a reservoir solution consisting of 6.5%–7% (w/v) polyeth-
ylene glycol 4000, 0.4–0.6 M potassium acetate, and 100 mM MES (pH 5.75).
Data Collection and Structure Determination
Crystals were cryo-protected by soaking in mother liquor containing
increasing concentrations (5%–30%, v/v) of glycerol, flash cooled in liquid ni-
trogen, and data collection was performed at 100 K. Data were collected at
beamline ID29 (ESRF) and processed using XDS (Kabsch, 2010). For subse-
quent calculations, the CCP4 suite (Winn et al., 2011) and Phenix (Adams
et al., 2010) were utilized. Phases were obtained bymolecular replacement us-
ing Phaser (McCoy et al., 2007) searching for two trimers (PDB: 3CF3; Davies
et al., 2008). The structure was refined with Phenix incorporating non-crystal-
lographic symmetry restraints and TLS refinement in all cycles.
In Vitro Binding Assays
ITC experiments were conducted as described (Ha¨nzelmann et al., 2011),
using 50 mM Tris (pH 8), 150 mM KCl, and 5 mMMgCl2 as buffer. In all exper-
iments, a 15-foldmolar excess of UFD1/NPL4 or p47was titrated into the sam-
ple cell containing 10 mM p97ND1. A volume of 10 ml of ligand was added at a
time, with a total of 30 injections. All experiments were performed using a VP-
ITC instrument (MicroCal, GE Healthcare) at 25C. Data were analyzed with a
single-site binding model using the software supplied by the ITCmanufacturer
and nonlinear least-squares fitting to calculate the KD. Pull-down assays using
biotinylated or GST-tagged peptides were performed as previously described
(Ha¨nzelmann and Schindelin, 2011). Biotinylated peptides or GST-tagged pro-
teins were immobilized on Strep-Tactin Sepharose beads (IBA BioTAGnology)146 Structure 24, 140–147, January 5, 2016 ª2016 Elsevier Ltd All rigor glutathione Sepharose beads (GSH, Novagen). In all experiments, 10 ml
of beadswere incubatedwith 12.5 mMbiotinylated peptides/1 mMGST-tagged
proteins in 200 ml of PBS buffer (pH 7.4) with 0.1% (v/v) Triton X-100 at 4C for
1 hr. p97ND1 alone was included as control. After centrifugation (1,250 3 g,
30 s) beads were washed four times with 400 ml of binding buffer. Equimolar
amounts of purified p97ND1 and variants in a total volume of 200 ml of binding
buffer were added to immobilized peptides, and treated in the same way as
in the first step. Immobilized proteins were directly analyzed by 15% (v/v)
SDS-PAGE.
ACCESSION NUMBERS
Atomic coordinates and structure factors have been deposited in the PDBwith
accession code PDB: 5C1B.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at http://dx.doi.org/10.1016/j.str.2015.10.027.
ACKNOWLEDGMENTS
This work was supported by theDeutsche Forschungsgemeinschaft (HA 3405/
3-1 and the Rudolf Virchow Center for Experimental Biomedicine, FZ 82) to
P.H. and H.S. We thank Dr. Antje Scha¨fer for critical reading of the manuscript.
Received: June 15, 2015
Revised: October 29, 2015
Accepted: October 30, 2015
Published: December 17, 2015
REFERENCES
Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N.,
Headd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010).
PHENIX: a comprehensive Python-based system for macromolecular struc-
ture solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221.
Alexandru, G., Graumann, J., Smith, G.T., Kolawa, N.J., Fang, R., and
Deshaies, R.J. (2008). UBXD7 binds multiple ubiquitin ligases and implicates
p97 in HIF1alpha turnover. Cell 134, 804–816.
Ballar, P., Shen, Y., Yang, H., and Fang, S. (2006). The role of a novel p97/va-
losin-containing protein-interacting motif of gp78 in endoplasmic reticulum-
associated degradation. J. Biol. Chem. 281, 35359–35368.
Bebeacua, C., Forster, A., McKeown, C., Meyer, H.H., Zhang, X., and
Freemont, P.S. (2012). Distinct conformations of the protein complex p97-
Ufd1-Npl4 revealed by electron cryomicroscopy. Proc. Natl. Acad. Sci. USA
109, 1098–1103.
Beuron, F., Dreveny, I., Yuan, X., Pye, V.E., McKeown, C., Briggs, L.C., Cliff,
M.J., Kaneko, Y., Wallis, R., Isaacson, R.L., et al. (2006). Conformational
changes in the AAA ATPase p97-p47 adaptor complex. EMBO J. 25, 1967–
1976.
Bruderer, R.M., Brasseur, C., and Meyer, H.H. (2004). The AAA ATPase p97/
VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a
common bipartite binding mechanism. J. Biol. Chem. 279, 49609–49616.
Buchberger, A., Schindelin, H., and Ha¨nzelmann, P. (2015). Control of p97
function by cofactor binding. FEBS Lett. 589, 2578–2589.
Davies, J.M., Brunger, A.T., and Weis, W.I. (2008). Improved structures of full-
length p97, an AAA ATPase: implications for mechanisms of nucleotide-
dependent conformational change. Structure 16, 715–726.
Dreveny, I., Kondo, H., Uchiyama, K., Shaw, A., Zhang, X., and Freemont, P.S.
(2004). Structural basis of the interaction between the AAA ATPase p97/VCP
and its adaptor protein p47. EMBO J. 23, 1030–1039.
Ernst, R., Mueller, B., Ploegh, H.L., and Schlieker, C. (2009). The otubain YOD1
is a deubiquitinating enzyme that associates with p97 to facilitate protein dislo-
cation from the ER. Mol. Cell 36, 28–38.hts reserved
Fernandez-Saiz, V., and Buchberger, A. (2010). Imbalances in p97 co-factor
interactions in human proteinopathy. EMBO Rep. 11, 479–485.
Greenblatt, E.J., Olzmann, J.A., and Kopito, R.R. (2011). Derlin-1 is a rhomboid
pseudoprotease required for the dislocation of mutant alpha-1 antitrypsin from
the endoplasmic reticulum. Nat. Struct. Mol. Biol. 18, 1147–1152.
Ha¨nzelmann, P., and Schindelin, H. (2011). The structural and functional basis
of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually
exclusive binding of cofactors to the N-terminal domain of p97. J. Biol.
Chem. 286, 38679–38690.
Ha¨nzelmann, P., Buchberger, A., and Schindelin, H. (2011). Hierarchical bind-
ing of cofactors to the AAA ATPase p97. Structure 19, 833–843.
Huang, C.H., Hsiao, H.T., Chu, Y.R., Ye, Y., and Chen, X. (2013). Derlin2 pro-
tein facilitates HRD1-mediated retro-translocation of sonic hedgehog at the
endoplasmic reticulum. J. Biol. Chem. 288, 25330–25339.
Huyton, T., Pye, V.E., Briggs, L.C., Flynn, T.C., Beuron, F., Kondo, H., Ma, J.,
Zhang, X., and Freemont, P.S. (2003). The crystal structure of murine p97/VCP
at 3.6 A˚. J. Struct. Biol. 144, 337–348.
Isaacson, R.L., Pye, V.E., Simpson, P., Meyer, H.H., Zhang, X., Freemont, P.S.,
and Matthews, S. (2007). Detailed structural insights into the p97-Npl4-Ufd1
interface. J. Biol. Chem. 282, 21361–21369.
Kabsch, W. (2010). Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132.
Kim, S.J., Cho, J., Song, E.J., Kim, H.M., Lee, K.E., Suh, S.W., and Kim, E.E.
(2014). Structural basis for ovarian tumor domain-containing protein 1
(OTU1) binding to p97/valosin-containing protein (VCP). J. Biol. Chem. 289,
12264–12274.
Kloppsteck, P., Ewens, C.A., Forster, A., Zhang, X., and Freemont, P.S. (2012).
Regulation of p97 in the ubiquitin-proteasome system by the UBX protein-fam-
ily. Biochim. Biophys. Acta 1823, 125–129.
Laser, H., Conforti, L., Morreale, G., Mack, T.G., Heyer, M., Haley, J.E.,
Wishart, T.M., Beirowski, B., Walker, S.A., Haase, G., et al. (2006). The slow
Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially
redistributes it within the nucleus. Mol. Biol. Cell 17, 1075–1084.
Liu, S., Fu, Q.S., Zhao, J., and Hu, H.Y. (2013a). Structural and mechanistic in-
sights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Biochim. Biophys. Acta 1834, 2672–2678.
Liu, S., Yang, H., Zhao, J., Zhang, Y.H., Song, A.X., and Hu, H.Y. (2013b).
NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8
to proteasome for degradation through the P97UFD1/NPL4 complex. J. Biol.
Chem. 288, 31339–31349.
McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C.,
and Read, R.J. (2007). Phaser crystallographic software. J. Appl. Crystallogr.
40, 658–674.
Meyer, H., and Weihl, C.C. (2014). The VCP/p97 system at a glance: connect-
ing cellular function to disease pathogenesis. J. Cell. Sci. 127, 3877–3883.
Meyer, H.H., Shorter, J.G., Seemann, J., Pappin, D., and Warren, G. (2000). A
complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin
and nuclear transport pathways. EMBO J. 19, 2181–2192.
Meyer, H., Bug, M., and Bremer, S. (2012). Emerging functions of the VCP/p97
AAA-ATPase in the ubiquitin system. Nat. Cell. Biol. 14, 117–123.Structure 24, 14Morreale, G., Conforti, L., Coadwell, J., Wilbrey, A.L., and Coleman, M.P.
(2009). Evolutionary divergence of valosin-containing protein/cell division cy-
cle protein 48 binding interactions among endoplasmic reticulum-associated
degradation proteins. FEBS J. 276, 1208–1220.
Mosbech, A., Gibbs-Seymour, I., Kagias, K., Thorslund, T., Beli, P., Povlsen,
L., Nielsen, S.V., Smedegaard, S., Sedgwick, G., Lukas, C., et al. (2012).
DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiq-
uitin-dependent responses to replication blocks. Nat. Struct. Mol. Biol. 19,
1084–1092.
Nagahama, M., Suzuki, M., Hamada, Y., Hatsuzawa, K., Tani, K., Yamamoto,
A., and Tagaya, M. (2003). SVIP is a novel VCP/p97-interacting protein whose
expression causes cell vacuolation. Mol. Biol. Cell 14, 262–273.
Ogura, T., and Wilkinson, A.J. (2001). AAA+ superfamily ATPases: common
structure–diverse function. Genes Cells 6, 575–597.
Park, S., Isaacson, R., Kim, H.T., Silver, P.A., and Wagner, G. (2005). Ufd1 ex-
hibits the AAA-ATPase fold with two distinct ubiquitin interaction sites.
Structure 13, 995–1005.
Pye, V.E., Beuron, F., Keetch, C.A., McKeown, C., Robinson, C.V., Meyer,
H.H., Zhang, X., and Freemont, P.S. (2007). Structural insights into the p97-
Ufd1-Npl4 complex. Proc. Natl. Acad. Sci. USA 104, 467–472.
Rumpf, S., and Jentsch, S. (2006). Functional division of substrate processing
cofactors of the ubiquitin-selective Cdc48 chaperone. Mol. Cell 21, 261–269.
Sato, B.K., and Hampton, R.Y. (2006). Yeast Derlin Dfm1 interacts with Cdc48
and functions in ER homeostasis. Yeast 23, 1053–1064.
Stolz, A., Hilt, W., Buchberger, A., and Wolf, D.H. (2011). Cdc48: a power ma-
chine in protein degradation. Trends Biochem. Sci. 36, 515–523.
Tang,W.K., Li, D., Li, C.C., Esser, L., Dai, R., Guo, L., and Xia, D. (2010). A novel
ATP-dependent conformation in p97 N-D1 fragment revealed by crystal struc-
tures of disease-related mutants. EMBO J. 29, 2217–2229.
Uchiyama, K., Jokitalo, E., Kano, F., Murata, M., Zhang, X., Canas, B.,
Newman, R., Rabouille, C., Pappin, D., Freemont, P., et al. (2002). VCIP135,
a novel essential factor for p97/p47-mediated membrane fusion, is required
for Golgi and ER assembly in vivo. J. Cell. Biol. 159, 855–866.
Wang, B., Alam, S.L., Meyer, H.H., Payne, M., Stemmler, T.L., Davis, D.R., and
Sundquist, W.I. (2003). Structure and ubiquitin interactions of the conserved
zinc finger domain of Npl4. J. Biol. Chem. 278, 20225–20234.
Wendler, P., Ciniawsky, S., Kock, M., and Kube, S. (2012). Structure and func-
tion of the AAA+ nucleotide binding pocket. Biochim. Biophys. Acta 1823,
2–14.
Winn, M.D., Ballard, C.C., Cowtan, K.D., Dodson, E.J., Emsley, P., Evans,
P.R., Keegan, R.M., Krissinel, E.B., Leslie, A.G., McCoy, A., et al. (2011).
Overview of the CCP4 suite and current developments. Acta Crystallogr. D
Biol. Crystallogr. 67, 235–242.
Ye, Y., Shibata, Y., Yun, C., Ron, D., and Rapoport, T.A. (2004). A membrane
protein complex mediates retro-translocation from the ER lumen into the
cytosol. Nature 429, 841–847.
Yeung, H.O., Kloppsteck, P., Niwa, H., Isaacson, R.L., Matthews, S., Zhang,
X., and Freemont, P.S. (2008). Insights into adaptor binding to the AAA protein
p97. Biochem. Soc. Trans. 36, 62–67.0–147, January 5, 2016 ª2016 Elsevier Ltd All rights reserved 147
